193 related articles for article (PubMed ID: 6331461)
21. An ultrastructural study of the articular cartilage in calcium pyrophosphate dihydrate (CPPD) crystal deposition disease (chondrocalcinosis articularis).
Bjelle AO; Sundström KG
Calcif Tissue Res; 1975 Nov; 19(1):63-71. PubMed ID: 172199
[TBL] [Abstract][Full Text] [Related]
22. Contribution of calcium-containing crystals to cartilage degradation and synovial inflammation in osteoarthritis.
Liu YZ; Jackson AP; Cosgrove SD
Osteoarthritis Cartilage; 2009 Oct; 17(10):1333-40. PubMed ID: 19447216
[TBL] [Abstract][Full Text] [Related]
23. [New knowledge on the calcium pyrophosphate dihydrate (CPPD) crystal deposition disease in the cervical ligamentum flavum].
Kawano N; Matsuno T; Miyazawa S; Uchiyama H; Ohtaka H; Mii K; Tachibana S
No Shinkei Geka; 1987 Feb; 15(2):181-90. PubMed ID: 3031524
[TBL] [Abstract][Full Text] [Related]
24. Effects of pyrophosphatase on dissolution of calcium pyrophosphate dihydrate crystals.
Xu Y; Cruz T; Cheng PT; Pritzker KP
J Rheumatol; 1991 Jan; 18(1):66-71. PubMed ID: 1850802
[TBL] [Abstract][Full Text] [Related]
25. Pyrophosphate, phosphate ion interaction: effects on calcium pyrophosphate and calcium hydroxyapatite crystal formation in aqueous solutions.
Cheng PT; Pritzker KP
J Rheumatol; 1983 Oct; 10(5):769-77. PubMed ID: 6315937
[TBL] [Abstract][Full Text] [Related]
26. [The solubility of calcium pyrophosphate dihydrate crystals].
Sakamoto H
Nihon Seikeigeka Gakkai Zasshi; 1995 Jul; 69(7):484-92. PubMed ID: 7561350
[TBL] [Abstract][Full Text] [Related]
27. Interaction of polymorphonuclear leukocytes with calcium pyrophosphate dihydrate crystals deposited in chondrocalcinosis cartilage.
Ishikawa H; Ueba Y; Isobe T; Hirohata K
Rheumatol Int; 1987; 7(5):217-21. PubMed ID: 2827293
[TBL] [Abstract][Full Text] [Related]
28. Calcium pyrophosphate dihydrate crystal deposition and other crystal deposition diseases.
Pritzker KP
Curr Opin Rheumatol; 1994 Jul; 6(4):442-7. PubMed ID: 8068517
[TBL] [Abstract][Full Text] [Related]
29. Cartilage intermediate layer protein expression in calcium pyrophosphate dihydrate crystal deposition disease.
Yamakawa K; Iwasaki H; Masuda I; Ohjimi Y; Honda I; Iyama K; Shono E; Naito M; Kikuchi M
J Rheumatol; 2002 Aug; 29(8):1746-53. PubMed ID: 12180739
[TBL] [Abstract][Full Text] [Related]
30. Calcium pyrophosphate dihydrate crystal deposition disease.
Bencardino JT; Hassankhani A
Semin Musculoskelet Radiol; 2003 Sep; 7(3):175-85. PubMed ID: 14593559
[TBL] [Abstract][Full Text] [Related]
31. Formation of calcium pyrophosphate crystals: biologic implications.
Rosenthal AK
Curr Opin Rheumatol; 2000 May; 12(3):219-22. PubMed ID: 10803752
[TBL] [Abstract][Full Text] [Related]
32. [Study on identification of a calcium pyrophosphate dihydrate crystal using electron diffraction technique].
Watanabe W
Nihon Seikeigeka Gakkai Zasshi; 1991 Sep; 65(9):745-56. PubMed ID: 1960475
[TBL] [Abstract][Full Text] [Related]
33. [A clinical study of calcium pyrophosphate dihydrate crystal deposition disease].
Ogata M
Nihon Seikeigeka Gakkai Zasshi; 1985 Aug; 59(8):819-34. PubMed ID: 3003215
[TBL] [Abstract][Full Text] [Related]
34. Up-regulated expression of cartilage intermediate-layer protein and ANK in articular hyaline cartilage from patients with calcium pyrophosphate dihydrate crystal deposition disease.
Hirose J; Ryan LM; Masuda I
Arthritis Rheum; 2002 Dec; 46(12):3218-29. PubMed ID: 12483726
[TBL] [Abstract][Full Text] [Related]
35. Clinical aspects of calcium pyrophosphate dihydrate crystal deposition.
Doherty M; Dieppe P
Rheum Dis Clin North Am; 1988 Aug; 14(2):395-414. PubMed ID: 2845493
[TBL] [Abstract][Full Text] [Related]
36. Alkaline phosphatase dissolves calcium pyrophosphate dihydrate crystals.
Xu Y; Cruz TF; Pritzker KP
J Rheumatol; 1991 Oct; 18(10):1606-10. PubMed ID: 1765989
[TBL] [Abstract][Full Text] [Related]
37. The prevalence of and factors related to calcium pyrophosphate dihydrate crystal deposition in the knee joint.
Ryu K; Iriuchishima T; Oshida M; Kato Y; Saito A; Imada M; Aizawa S; Tokuhashi Y; Ryu J
Osteoarthritis Cartilage; 2014 Jul; 22(7):975-9. PubMed ID: 24814686
[TBL] [Abstract][Full Text] [Related]
38. Calcium pyrophosphate dihydrate (CPPD) crystal dissolution by alkaline phosphatase: interaction of alkaline phosphatase on CPPD crystals.
Shinozaki T; Xu Y; Cruz TF; Pritzker KP
J Rheumatol; 1995 Jan; 22(1):117-23. PubMed ID: 7699658
[TBL] [Abstract][Full Text] [Related]
39. Regulation of alkaline phosphatase: implications for calcium pyrophosphate dihydrate crystal dissolution and other alkaline phosphatase functions.
Shinozaki T; Pritzker KP
J Rheumatol; 1996 Apr; 23(4):677-83. PubMed ID: 8730126
[TBL] [Abstract][Full Text] [Related]
40. The interaction of monoclinic calcium pyrophosphate dihydrate crystals with neutrophils.
Winternitz CI; Jackson JK; Burt HM
Rheumatol Int; 1996; 16(3):101-7. PubMed ID: 8893374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
